Role of angiotensin converting enzyme inhibitor [captopril] in proteinuria, glomerular filtration rate and lipid profile in NIDDM patients
Pakistan Journal of Pharmacology. 2002; 19 (2): 47-53
en Inglés
| IMEMR
| ID: emr-60504
ABSTRACT
Clinical trial has shown the beneficial effects of captopril in delaying the progression of diabetic renal disease. We performed an analysis to determine in efficacy of captopril in slowing the progression of renal disease over a broad range of functional renal and extra renal impairment. Treatment of individuals with microscopic and macroscopic proteinuria in NIDDM patients with preexisting hypertension and hyperlipidemia by captopril delays, inhibit or even revert the disease
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Proteinuria
/
Captopril
/
Diabetes Mellitus Tipo 2
/
Tasa de Filtración Glomerular
/
Lípidos
Límite:
Humanos
Idioma:
Inglés
Revista:
Pak. J. Pharmacol.
Año:
2002
Similares
MEDLINE
...
LILACS
LIS